| Primary |
| Parkinson's Disease |
48.7% |
| Schizophrenia |
21.8% |
| Blepharospasm |
5.1% |
| Depression |
3.8% |
| Drug Dependence |
3.8% |
| Dystonia |
3.8% |
| Dementia |
2.6% |
| Parkinsonism |
2.6% |
| Adverse Drug Reaction |
1.3% |
| Dyskinesia |
1.3% |
| Glaucoma |
1.3% |
| Porencephaly |
1.3% |
| Prophylaxis |
1.3% |
| Rheumatoid Arthritis |
1.3% |
|
| Eyelid Ptosis |
12.1% |
| Asthenia |
6.1% |
| Dementia |
6.1% |
| Drug Ineffective |
6.1% |
| Face Oedema |
6.1% |
| Haematuria |
6.1% |
| Hallucination, Auditory |
6.1% |
| Hepatic Neoplasm Malignant |
6.1% |
| Neuroleptic Malignant Syndrome |
6.1% |
| Psychomotor Hyperactivity |
6.1% |
| Renal Impairment |
6.1% |
| Altered State Of Consciousness |
3.0% |
| Asthenopia |
3.0% |
| Blood Creatine Phosphokinase Increased |
3.0% |
| Blood Insulin Increased |
3.0% |
| Blood Pressure Decreased |
3.0% |
| Confusional State |
3.0% |
| Convulsion |
3.0% |
| Dyskinesia |
3.0% |
| Ill-defined Disorder |
3.0% |
|
| Secondary |
| Parkinson's Disease |
28.5% |
| Drug Use For Unknown Indication |
19.6% |
| Product Used For Unknown Indication |
12.0% |
| Schizophrenia |
9.4% |
| Depression |
3.5% |
| Anxiety |
3.2% |
| Epilepsy |
3.2% |
| Drug Exposure During Pregnancy |
2.9% |
| Psychotic Disorder |
2.1% |
| Pyrexia |
1.9% |
| Extrapyramidal Disorder |
1.8% |
| Autism |
1.7% |
| Dystonia |
1.7% |
| Ill-defined Disorder |
1.4% |
| Parkinsonism |
1.4% |
| Constipation |
1.2% |
| Pharyngitis |
1.2% |
| Torticollis |
1.2% |
| Drug Effect Decreased |
1.1% |
| Agitation |
1.0% |
|
| Tremor |
12.9% |
| Tachycardia |
9.9% |
| Somnolence |
8.9% |
| Visual Impairment |
7.9% |
| Neuroleptic Malignant Syndrome |
6.9% |
| Psychiatric Symptom |
5.9% |
| Hepatitis Fulminant |
5.0% |
| Cardiac Failure Acute |
4.0% |
| Epilepsy |
4.0% |
| Pneumonia |
4.0% |
| Rhabdomyolysis |
4.0% |
| Weight Decreased |
4.0% |
| Hearing Impaired |
3.0% |
| Hypersexuality |
3.0% |
| Neurogenic Bladder |
3.0% |
| Off Label Use |
3.0% |
| Rash Generalised |
3.0% |
| Shock |
3.0% |
| Vertigo |
3.0% |
| Asthenopia |
2.0% |
|
| Concomitant |
| Parkinson's Disease |
28.3% |
| Schizophrenia |
14.9% |
| Drug Use For Unknown Indication |
8.6% |
| Product Used For Unknown Indication |
8.2% |
| Depression |
7.7% |
| Hypertension |
4.9% |
| Anxiety |
3.4% |
| Insomnia |
2.8% |
| Bipolar Disorder |
2.6% |
| Psychotic Disorder |
2.6% |
| Parkinsonism |
2.1% |
| Constipation |
1.8% |
| Prophylaxis |
1.7% |
| Epilepsy |
1.7% |
| Pain |
1.7% |
| Tremor |
1.6% |
| Diabetes Mellitus |
1.5% |
| Torticollis |
1.4% |
| Extrapyramidal Disorder |
1.3% |
| Sleep Disorder |
1.3% |
|
| Weight Increased |
14.3% |
| Tremor |
10.3% |
| Sudden Onset Of Sleep |
7.6% |
| Weight Decreased |
6.3% |
| Pathological Gambling |
5.6% |
| Rhabdomyolysis |
5.6% |
| White Blood Cell Count Decreased |
4.7% |
| Death |
4.0% |
| Psychotic Disorder |
4.0% |
| Tardive Dyskinesia |
4.0% |
| Pyrexia |
3.7% |
| Somnolence |
3.7% |
| Suicidal Ideation |
3.7% |
| Suicide Attempt |
3.7% |
| Vomiting |
3.7% |
| Pneumonia |
3.3% |
| Sepsis |
3.3% |
| Drug Ineffective |
3.0% |
| White Blood Cell Count Increased |
3.0% |
| Gastric Ulcer |
2.7% |
|
| Interacting |
| Psychotic Disorder |
27.0% |
| Parkinson's Disease |
18.9% |
| Hypertension |
10.8% |
| Schizophrenia |
10.8% |
| Agitation |
5.4% |
| Cancer Pain |
5.4% |
| Drug Use For Unknown Indication |
5.4% |
| Depression |
2.7% |
| Headache |
2.7% |
| Lipids Abnormal |
2.7% |
| Schizophrenia Simple |
2.7% |
| Simple Schizophrenia |
2.7% |
| Smoking Cessation Therapy |
2.7% |
|
| Drug Interaction |
33.3% |
| Malaise |
22.2% |
| Somnolence |
22.2% |
| Inhibitory Drug Interaction |
11.1% |
| Sudden Onset Of Sleep |
11.1% |
|
